Impact and Management of Norovirus in United States: A Public Health Perspective
preprint
OA: closed
AI-generated summary
Norovirus causes significant public health and economic burdens in the US, necessitating improved surveillance, policy, and awareness due to limited treatments and vaccines.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Norovirus is a leading cause of acute gastroenteritis in the United States imposing a significant burden on public health and the economy. Its highly contagious nature and ability to persist in the environment make norovirus a persistent challenge in healthcare, educational, and food service settings. The lack of specific antiviral treatments or licensed vaccines complicates management efforts, leaving prevention strategies reliant on hygiene practices, food safety measures, and outbreak control protocols. Emerging research into vaccine development and novel mitigation approaches offers promise but remains in the early stages. This review synthesizes current knowledge on norovirus impact and management in the United States, emphasizing the need for enhanced surveillance, policy reforms, and public awareness to reduce its prevalence and mitigate future outbreaks.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- europepmc
- last seen: 2026-05-20T01:45:00.602351+00:00